We compared the analytical and clinical performance of cobas® CT/NG for use on the cobas® 6800/8800 Systems with the cobas® 4800 CT/NG Test from urogenital and extragenital specimens in over 12,000 specimens from both male and female subjects in Germany and the United States. The analytical sensitivity was ≤40 EB/ml for Chlamydia trachomatis (CT) and ≤1 CFU/ml for Neisseria gonorrhoeae (NG). Using clinical specimens, the overall percent agreement with the cobas® 4800 CT/NG Test was >98.5%. Across urogenital specimens, there were 93 discrepant specimens; 76 (93.8%) of 81 CT discrepant specimens were 6800+/4800− and 10 (83.3%) of 12 NG discrepant specimens were 6800+/4800−. Sequencing verified CT results for 45 (61.6%) of 73 samples positive by 6800 and 1 (20%) of 5 positive by 4800. Similarly, 7 (70.0%) of 10 NG samples positive by 6800 and 1 of 2 positive by 4800 were confirmed by sequencing. Among discrepant extragenital specimens (all 6800+/4800−), 7 (50%) of 14 oropharyngeal and 23 (76.7%) of 30 anorectal CT discordant samples were confirmed as CT positive by sequencing; all 8 anorectal and 20 (90.9%) of 22 oropharyngeal NG discordant results were also confirmed as NG positive. In conclusion, cobas® CT/NG for use on the cobas® 6800/8800 Systems provides high-throughput automated solutions for sexually transmitted infection (STI) screening programs.
Detels R , Green AM, Klausner JD, Katzenstein D, Gaydos C, Handsfield H, Pequegnat W, Mayer K, Hartwell TD, Quinn TC: The incidence and correlates of symptomatic and asymptomatic Chlamydia trachomatis and Neisseria gonorrhoeae infections in selected populations in five countries. Sex Transm Dis 38, 503–509 (2011)
Newman L , Rowley J, Vander Hoorn S, Wijesooriya NS, Unemo M, Low N, Stevens G, Gottlieb S, Kiarie J, Temmerman M: Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PLoS One 10, e0143304 (2015)
Price MJ , Ades AE, De Angelis D, Welton NJ, Macleod J, Soldan K, Simms I, Turner K, Horner PJ: Risk of pelvic inflammatory disease following Chlamydia trachomatis infection: analysis of prospective studies with a multistate model. Am J Epidemiol 178, 484–492 (2013)
Gottlieb SL , Xu F, Brunham RC: Screening and treating Chlamydia trachomatis genital infection to prevent pelvic inflammatory disease: interpretation of findings from randomized controlled trials. Sex Transm Dis 40, 97–102 (2013)
Rekart ML , Gilbert M, Meza R, Kim PH, Chang M, Money DM, Brunham RC: Chlamydia public health programs and the epidemiology of pelvic inflammatory disease and ectopic pregnancy. J Infect Dis 207, 30–38 (2013)
Romoren M , Hussein F, Steen TW, Velauthapillai M, Sundby J, Hjortdahl P, Kristiansen IS: Costs and health consequences of chlamydia management strategies among pregnant women in sub-Saharan Africa. Sex Transm Infect 83, 558–566 (2007)
Sexton J , Garnett G, Rottingen JA: Metaanalysis and metaregression in interpreting study variability in the impact of sexually transmitted diseases on susceptibility to HIV infection. Sex Transm Dis 32, 351–357 (2005)
Workowski KA , Bolan GA, Centers for Disease C, Prevention: Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 64, 1–137 (2015)
Kent CK , Chaw JK, Wong W, Liska S, Gibson S, Hubbard G, Klausner JD: Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003. Clin Infect Dis 41, 67–74 (2005)
Annan NT , Sullivan AK, Nori A, Naydenova P, Alexander S, McKenna A, Azadian B, Mandalia S, Rossi M, Ward H, Nwokolo N: Rectal chlamydia — a reservoir of undiagnosed infection in men who have sex with men. Sex Transm Infect 85, 176–179 (2009)
Gunn RA , O’Brien CJ, Lee MA, Gilchick RA: Gonorrhea screening among men who have sex with men: value of multiple anatomic site testing, San Diego, California, 1997–2003. Sex Transm Dis 35, 845–848 (2008)
Ota KV , Fisman DN, Tamari IE, Smieja M, Ng LK, Jones KE, Diprima A, Richardson SE: Incidence and treatment outcomes of pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections in men who have sex with men: a 13-year retrospective cohort study. Clin Infect Dis 48, 1237–1243 (2009)
Schachter J , Moncada J, Liska S, Shayevich C, Klausner JD: Nucleic acid amplification tests in the diagnosis of chlamydial and gonococcal infections of the oropharynx and rectum in men who have sex with men. Sex Transm Dis 35, 637–642 (2008)
Centers for Disease Control and Prevention: Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae — 2014. MMWR Recomm Rep 63, 1–19 (2014)
Javanbakht M , Gorbach P, Stirland A, Chien M, Kerndt P, Guerry S: Prevalence and correlates of rectal chlamydia and gonorrhea among female clients at sexually transmitted disease clinics. Sex Transm Dis 39, 917–922 (2012)
van Liere GA , Hoebe CJ, Wolffs PF, Dukers-Muijrers NH: High co-occurrence of anorectal chlamydia with urogenital chlamydia in women visiting an STI clinic revealed by routine universal testing in an observational study; a recommendation towards a better anorectal chlamydia control in women. BMC Infect Dis 14, 274 (2014)
van Liere G , Dukers-Muijrers N, Levels L, Hoebe C: High proportion of anorectal Chlamydia trachomatis and Neisseria gonorrhoeae after routine universal urogenital and anorectal screening in women visiting the sexually transmitted infection clinic. Clin Infect Dis 64, 1705–1710 (2017)
Volk JE , Marcus JL, Phengrasamy T, Blechinger D, Nguyen DP, Follansbee S, Hare CB: No new HIV infections with increasing use of HIV preexposure prophylaxis in a clinical practice setting. Clin Infect Dis 61, 1601–1603 (2015)
Van Der Pol B : Cobas(R) 4800: a fully automated system for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae. Expert Rev Mol Diagn 13, 131–140 (2013)
Van Der Pol B , Liesenfeld O, Williams JA, Taylor SN, Lillis RA, Body BA, Nye M, Eisenhut C, Hook EW 3rd: Performance of the cobas CT/NG test compared to the Aptima AC2 and Viper CTQ/GCQ assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol 50, 2244–2249 (2012)
Van Der Pol B , Taylor SN, Liesenfeld O, Williams JA, Hook EW, 3rd: Vaginal swabs are the optimal specimen for detection of genital Chlamydia trachomatis or Neisseria gonorrhoeae using the Cobas 4800 CT/NG test. Sex Transm Dis 40, 247–250 (2013)
Taylor SN , Liesenfeld O, Lillis RA, Body BA, Nye M, Williams J, Eisenhut C, Hook EW 3rd, Van Der Pol B: Evaluation of the Roche cobas(R) CT/NG test for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in male urine. Sex Transm Dis 39, 543–549 (2012)
Cobb B , Simon CO, Stramer SL, Body B, Mitchell PS, Reisch N, Stevens W, Carmona S, Katz L, Will S, Liesenfeld O: The cobas(R) 6800/8800 System: a new era of automation in molecular diagnostics. Expert Rev Mol Diagn 17, 167–180 (2017)
Zaninotto M , Plebani M: The “hospital central laboratory”: automation, integration and clinical usefulness. Clin Chem Lab Med 48, 911–917 (2010)
Ledeboer NA , Dallas SD: The automated clinical microbiology laboratory: fact or fantasy? J Clin Microbiol 52, 3140–3146 (2014)
Kojima N , Davey DJ, Klausner JD: Pre-exposure prophylaxis for HIV infection and new sexually transmitted infections among men who have sex with men. AIDS 30, 2251–2252 (2016)
Jenness SM , Weiss KM, Goodreau SM, Gift T, Chesson H, Hoover KW, Smith DK, Liu AY, Sullivan PS, Rosenberg ES: Incidence of gonorrhea and chlamydia following HIV preexposure prophylaxis among men who have sex with men: a modeling study. Clin Infect Dis 65, 712–718 (2017), DOI: 10.1093/cid/cix439 (2017)
US Public Health Service Preexposure prophylaxis for the prevention of HIV infection in the United States — 2014: a clinical practice guideline. https://wwwcdcgov/hiv/pdf/prepguidelines2014pdf (2014)
Tabrizi SN , Unemo M, Limnios AE, Hogan TR, Hjelmevoll SO, Garland SM, Tapsall J: Evaluation of six commercial nucleic acid amplification tests for detection of Neisseria gonorrhoeae and other Neisseria species. J Clin Microbiol 49, 3610–3615 (2011)
Upton A , Bromhead C, Whiley DM: Neisseria gonorrhoeae false-positive result obtained from a pharyngeal swab by using the Roche cobas 4800 CT/NG assay in New Zealand in 2012. J Clin Microbiol 51, 1609–1610 (2013)
Bohm I , Groning A, Sommer B, Muller HW, Krawczak M, Glaubitz R: A German Chlamydia trachomatis screening program employing semi-automated real-time PCR: results and perspectives. J Clin Virol 46 (Suppl 3), S27–S32 (2009)